Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Safety and Efficacy Comparison of BLI4700 Bowel Prep Versus an FDA-approved Comparator in Adults Prior to Colonoscopy

ClinicalTrials.gov ID: NCT03404401

Public ClinicalTrials.gov record NCT03404401. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 9:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

BLI4700-301: A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to compare the safety and efficacy of BLI4700 bowel preparation to an FDA-approved bowel preparation as 2-day, split-dose bowel preparations prior to colonoscopy in adult patients.

Study identification

NCT ID
NCT03404401
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Braintree Laboratories
Industry
Enrollment
620 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 11, 2018 (Actual)
Primary completion
Jul 10, 2018 (Actual)
Completion
Jul 10, 2018 (Actual)
Last update posted
Sep 8, 2021

2018

United States locations

U.S. sites
23
U.S. states
15
U.S. cities
23
Facility City State ZIP Site status
Braintree Research Site 212 Mobile Alabama 36688 —
Braintree Research Site 204 Tucson Arizona 85712 —
Braintree Research Site 209 Anaheim California 92801 —
Braintree Research Site 219 Chula Vista California 91910 —
Braintree Research Site 206 Los Angeles California 90045 —
Braintree Research Site 220 San Diego California 92114 —
Braintree Research Site 221 Inverness Florida 34452 —
Braintree Research Site 222 Jacksonville Florida 32216 —
Braintree Research Site 201 Palm Harbor Florida 34684 —
Braintree Research Site 224 Atlanta Georgia 30342 —
Braintree Research Site 215 Decatur Georgia 30033 —
Braintree Research Site 223 Lake Charles Louisiana 70601 —
Braintree Research Site 211 Monroe Louisiana 71201 —
Braintree Research Site 207 Hagerstown Maryland 21742 —
Braintree Research Site 218 Flowood Mississippi 39232 —
Braintree Research Site 210 Great Neck New York 11023 —
Braintree Research Site 214 Cincinnati Ohio 45219 —
Braintree Research Site 213 Portland Oregon 97210 —
Braintree Research Site 216 Columbia South Carolina 29203 —
Braintree Research Site 202 Franklin Tennessee 37067 —
Braintree Research Site 203 Jackson Tennessee 38305 —
Braintree Research Site 217 Ogden Utah 84405 —
Braintree Research Site 208 Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03404401, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 8, 2021 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03404401 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →